PRL3 expression in pediatric tumor specimens is associated with elevation of pro-angiogenic factors and phosphorylation of G-protein-coupled receptor (GPCR)-mitogen-activated protein kinase (MAPK) pathway members. The gene discussed is PTP4A3; the disease is neoplasm.